Cosmo Pharmaceuticals
C43.F
#5640
Rank
NZ$1.52 B
Marketcap
$95.34
Share price
-2.91%
Change (1 day)
-27.05%
Change (1 year)

EPS for Cosmo Pharmaceuticals (C43.F)

EPS in 2022: $1.89

According to Cosmo Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.89. In 2022 the company made an earnings per share (EPS) of $1.89 a decrease over its 2021 EPS that were of $2.45.

EPS history for Cosmo Pharmaceuticals from 2004 to 2022

Annual EPS

Year EPS Change
2022$1.89-22.92%
2021$2.45-317.03%
2020-$1.13-64.08%
2019-$3.1436.19%
2018-$2.31-47.81%
2017-$4.42-282.25%
2016$2.42-92.5%
2015$32.32209.32%
2014$10.45-6.29%
2013$11.15255.93%
2012$3.13173.6%
2011$1.14107.49%
2010$0.55-22.27%
2009$0.71-55.54%
2008$1.607392.2%
2007$0.02131-124.39%
2006-$0.08738-113.4%
2005$0.65-129.97%
2004-$2.18